Neocortical GABA release at high intracellular sodium and low extracellular calcium: an anti-seizure mechanism

J Neurochem. 2016 Apr;137(2):177-89. doi: 10.1111/jnc.13555. Epub 2016 Mar 1.

Abstract

In epilepsy, the GABA and glutamate balance may be disrupted and a transient decrease in extracellular calcium occurs before and during a seizure. Flow Cytometry based fluorescence activated particle sorting experiments quantified synaptosomes from human neocortical tissue, from both epileptic and non-epileptic patients (27.7% vs. 36.9% GABAergic synaptosomes, respectively). Transporter-mediated release of GABA in human and rat neocortical synaptosomes was measured using the superfusion technique for the measurement of endogenous GABA. GABA release was evoked by either a sodium channel activator or a sodium/potassium-ATPase inhibitor when exocytosis was possible or prevented, and when the sodium/calcium exchanger was active or inhibited. The transporter-mediated release of GABA is because of elevated intracellular sodium. A reduction in the extracellular calcium increased this release (in both non-epileptic and epileptic, except Rasmussen encephalitis, synaptosomes). The inverse was seen during calcium doubling. In humans, GABA release was not affected by exocytosis inhibition, that is, it was solely transporter-mediated. However, in rat synaptosomes, an increase in GABA release at zero calcium was only exhibited when the exocytosis was prevented. The absence of calcium amplified the sodium/calcium exchanger activity, leading to elevated intracellular sodium, which, together with the stimulation-evoked intracellular sodium increment, enhanced GABA transporter reversal. Sodium/calcium exchange inhibitors diminished GABA release. Thus, an important seizure-induced extracellular calcium reduction might trigger a transporter- and sodium/calcium exchanger-related anti-seizure mechanism by augmenting transporter-mediated GABA release, a mechanism absent in rats. Uniquely, the additional increase in GABA release because of calcium-withdrawal dwindled during the course of illness in Rasmussen encephalitis. Seizures cause high Na(+) influx through action potentials. A transient decrease in [Ca(2+)]e (seizure condition) increases GABA transporter (GAT)-mediated GABA release because of elevated [Na(+)]i. This amplifies the Sodium-Calcium-Exchanger (NCX) activity, further increasing [Na(+)]i and GABA release. The reduction in [Ca(2+)]e triggers a GAT-NCX related anti-seizure mechanism by augmenting GAT-mediated GABA release. This mechanism, obvious in humans, is absent in rats.

Keywords: GABA transporter; Na+/Ca2+ exchanger; Superfusion; epilepsy; fluorescence-activated sorting; human neocortical synaptosomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aniline Compounds / pharmacology
  • Animals
  • Calcium / metabolism*
  • Child
  • Child, Preschool
  • Enzyme Inhibitors / pharmacology
  • Female
  • GABA Plasma Membrane Transport Proteins / metabolism
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Neocortex / metabolism*
  • Neocortex / pathology*
  • Neurotoxins / pharmacology
  • Ouabain / pharmacology
  • Phenyl Ethers / pharmacology
  • Rats
  • Rats, Wistar
  • Seizures / pathology*
  • Sodium / metabolism*
  • Synaptosomes / drug effects
  • Synaptosomes / metabolism*
  • Tetanus Toxin / pharmacology
  • Thiourea / analogs & derivatives
  • Thiourea / pharmacology
  • Tritium / metabolism
  • Veratridine / pharmacology
  • Young Adult

Substances

  • 2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonate
  • Aniline Compounds
  • Enzyme Inhibitors
  • GABA Plasma Membrane Transport Proteins
  • Neurotoxins
  • Phenyl Ethers
  • SEA 0400
  • Tetanus Toxin
  • Tritium
  • Ouabain
  • Veratridine
  • Sodium
  • Thiourea
  • Calcium